0.69
-0.0176(-2.50%)
Currency In USD
| Previous Close | 0.7 |
| Open | 0.7 |
| Day High | 0.73 |
| Day Low | 0.67 |
| 52-Week High | 11.41 |
| 52-Week Low | 0.61 |
| Volume | 304,584 |
| Average Volume | 904,520 |
| Market Cap | 62.12M |
| PE | -0.37 |
| EPS | -1.84 |
| Moving Average 50 Days | 1.1 |
| Moving Average 200 Days | 4.55 |
| Change | -0.02 |
If you invested $1000 in Verrica Pharmaceuticals Inc. (VRCA) since IPO date, it would be worth $39.19 as of December 26, 2024 at a share price of $0.686. Whereas If you bought $1000 worth of Verrica Pharmaceuticals Inc. (VRCA) shares 5 years ago, it would be worth $42.87 as of December 26, 2024 at a share price of $0.686.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Verrica Provides Business and Operational Update
GlobeNewswire Inc.
Dec 20, 2024 12:00 PM GMT
-- Dispensed applicator units in the fourth quarter of 2024 have exceeded the complete prior quarter even with significant cost reductions in sales and operational infrastructure -- Observed significant reduction in YCANTH distributor inventory level
Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Dec 09, 2024 9:15 PM GMT
WEST CHESTER, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announ
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
GlobeNewswire Inc.
Dec 06, 2024 1:00 PM GMT
WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announ